Bioidentical Hormone Clinic

Dr Mantzourani gives a speech about "Acne and the gut-brain axis" at the AMWC 2017 in Monte Carlo

Dr Mantzourani's speech at the AMWC 2015 in Monte Carlo about compounding medication that will revolutionise clinical practice

Dr Mantzourani appearing on ITV news to comment on the recent study published in Lancet on HRT and ovarian cancer
http://www.itv.com/…/hrt-during-menopau se-can-increase-cha…/

Giving a speech at the 12th AMWC about biorhythmic BHRT with aim: To explore the influence of gonadal steroid hormones on circadian rhythmicity. To link the menstrual cycle with the timing of molecular clock. To stimulate the discussion about novel ways of BHRT delivery with view to preventing age-related diseases with a strong circadian connection. Finally, to propose a clinically applicable “biorhytmic” BHRT model.

Dr Mantzourani was a speaker at the 12th AMWC in Monaco. Watch a part of her speech! https://www.facebook.com/photo.php?v=7148 57638565848

Dr Mantzourani is a guest speaker at the 12th Anti-Aging Medicine World Congress in Monte Carlo with subject: "Biorhythmic" low dose BHRT: promising hormone optimisation therapy with physiological hormone level curves
http://www.euromedicom.com/flippingbook/A MWC2014/index.html…

Effectiveness of Compounded Bioidentical Hormone Replacement Therapy: An Observational Cohort Study
Abstract
... Background: Bioidentical Hormone Replacement Therapy (BHRT) is believed it to be a safer and equally effective alternative to Conventional Hormone Therapy for the relief of menopausal symptoms; however, data are needed to support these claims. The objective of this study is to evaluate the effectiveness of compounded BHRT provided in six community pharmacies.
Methods: This was an observational cohort study of women between the ages of 18-89 who received a compounded BHRT product from January 1, 2003 to April 30, 2010 in six community pharmacies. Data included patient demographics, comorbidities, therapeutic outcomes, and hormone therapies. Women self-rated menopausal symptoms as absent, mild, moderate, or severe. Descriptive statistics were used to characterize the patient population, BHRT use, and adverse events. Patient symptom severity was compared at baseline and 3 to 6 months follow-up using the Wilcoxon signed-rank test.
Results: Women (n = 296) receiving BHRT at Oakdell Pharmacy had a mean (standard deviation) age of 52 (9) years. The most common BHRT dosage forms utilized were topical (71%) and oral (43%). Compounded BHRT regimens were generally initiated at low doses regardless of route. Women experienced a 25% decrease in emotional lability (p < 0.01), a 25% decrease in irritability (p < 0.01), and a 22% reduction in anxiety (p = 0.01) within 3 to 6 months. These women also experienced a 14% reduction in night sweats (p = 0.09) and a 6% reduction in hot flashes (p = 0.50).
Conclusions: This study demonstrates that compounded BHRT improves mood symptoms. Larger studies are needed to examine the impact on vasomotor symptoms, myocardial infarction and breast cancer.
See More

Dr Mantzourani is a guest speaker at the annual congress of HSAAM with subject: "Bioidentical Hormone Replacement Therapy: From treating illness to treating individuals" http://www.hsaam2013.com/

All your questions about bioidentical hormones answered plus take a test online and find if you have the symptoms for menopause or andropause
http://www.drtheodoramantzourani.com/what arebioidenticalhor…

What is functional Medicine?
http://www.drtheodoramantzourani.com/1.ht ml

Check our new prices: http://www.drtheodoramantzourani.com/4.ht ml

Dr Theodora Mantzourani-Bioidentical Hormone Clinic-Functional Medicine

great service